Concert Pharmaceuticals, Inc.
NOVEL DEUTERATED JAK INHIBITOR AND USES THEREOF

Abstract:

Disclosed is a JAK1 and/or JAK2 inhibitor of the following structural formula: ##STR00001## or a pharmaceutically acceptable salt thereof. This invention also provides pharmaceutical compositions comprising a compound of Formula (I), optionally including additional therapeutic agents, and use in methods of treatment for hair loss disorders.